Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study

Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study

Recent meta-analyses show conflicting data on sex-dependent benefit following systemic treatment for advanced melanoma patients. We examined the nationwide Dutch Melanoma Treatment Registry (July 2013–July 2018), assessing sex-dependent differences in advanced melanoma patients (stage IIIC/IV) with...

Full description

Bibliographic Details
Main Authors: Monique K. van der Kooij, Olaf M. Dekkers, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Marye J. Boers-Sonderen, Jan Willem B. de Groot, Geke A. P. Hospers, Djura Piersma, Rozemarijn S. van Rijn, Karijn P. M. Suijkerbuijk, Hans M. Westgeest, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Sofie Wilgenhof, Michel W. J. M. Wouters, John B. A. G. Haanen, Alfonsus J. M. van den Eertwegh, Ellen Kapiteijn
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
sex
advanced melanoma
immunotherapy
targeted therapy
prospective nation-wide data
Online Access:https://www.mdpi.com/2072-6694/13/18/4639

Internet

https://www.mdpi.com/2072-6694/13/18/4639

Similar Items